Table 5.
ROC analysis of relevant variables in predicting ICAS.
| Female | Male | |||
|---|---|---|---|---|
| AUC(95% CI) | P value | AUC(95% CI) | P value | |
| VAI | 0.588(0.527–0.649) | 0.010 | 0.554(0.491–0.618) | 0.108 |
| LAP | 0.590(0.527–0.654) | 0.009 | 0.543(0.478–0.608) | 0.204 |
| FRS | 0.698(0.639–0.756) | <0.001 | 0.670(0.611–0.729) | <0.001 |
| Body mass index | 0.515 (0.447–0.583) | 0.667 | 0.533(0.468–0.598) | 0.334 |
| Triglyceride | 0.555(0.492–0.618) | 0.110 | 0.523(0.458–0.587) | 0.499 |
| HDL-C | 0.422(0.359–0.485) | 0.024 | 0.431(0.366–0.497) | 0.042 |
ROC, receiver operating characteristic; AUC, area under the ROC curve; 95% CI: 95% confidence intervals; VAI, visceral adiposity index; LAP, lipid accumulation product; FRS, Framingham risk score; HDL-C, high density lipoprotein cholesterol; ICAS, intracranial atherosclerotic stenosis.